Award

11404

Funder: Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital

Funded outputs count: 6

Funder award ID: 11404

OpenAlex ID: G1285994698

SGLT2 inhibitors and the risk of hepatocellular carcinoma in patients with MASLD and Type 2 diabetes

2025 · Ruey-Shyang Soong, Wan-Ming Chen, et al. · Diabetes & Metabolism · 7

GLP-1 receptor agonists and risk of hepatocellular carcinoma and all-cause mortality in patients with MASLD and type 2 diabetes: a propensity score–matched population-based cohort study

2025 · Wan-Ming Chen, Hui-Ji Ng, et al. · Diabetes Research and Clinical Practice · 16

Evaluating GLP-1 receptor agonists versus metformin as first-line therapy for reducing dementia risk in type 2 diabetes

2025 · Mingyang Sun, Xiaoling Wang, et al. · BMJ Open Diabetes Research & Care · 14

SGLT2is Versus Metformin for Delirium Prevention in Type 2 Diabetes: A Real-World, Head- to-Head Comparative Study

2025 · Mingyang Sun, Xiaoling Wang, et al. · Diabetes Care · 3

Sodium‐glucose cotransporter‐2 inhibitors and subtype‐specific dementia risk: A multinational and multiethnic cohort study

2025 · Mingyang Sun, Xiaoling Wang, et al. · Diabetes Obesity and Metabolism · 4

Metformin lowers risk of hearing loss and mortality in type 2 diabetes

2024 · Chun‐Chih Huang, Rui‐Fong Hsu, et al. · Diabetes Obesity and Metabolism · 7